A registration statement relating to these securities has been filed with the masterbatch business and achieve the expected results of the acquisitions, including, without limitation, the acquisitions being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisition and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. SEC Filings

FILE

SEC Filings

SEC Filings

COMPENSATION DISCUSSION AND ANALYSIS Tax Considerations. Name Company Contributions to Qualified Savings Plan ($) Company Contributions to PolyOne Supplemental Retirement Benefit Plan ($) Tax Gross-Ups ($) Standard Expatriate Benefits ($) Other Benefits ($) EXECUTIVE COMPENSATION Tax Gross-ups. Exercise or Base Price of Option Awards (column (i)) Grant Date Fair Value of Stock and Option Awards (column (j)) Narrative Disclosure Relating to the 2018 Summary Compensation Table and the 2018 Grants of Plan-Based Awards Table Outstanding Equity Awards at 2018 Fiscal Year-End Option Exercise Price ($) (e) Option Expiration Date (f) Market Value of Shares or Units of Stock That Have Not Vested ($) (h) Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested ($) (j) Name (a) Stock Awards Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) (d) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#) (i) Number of Shares or Units of Stock That Have Not Vested (#) (g) Number of Securities Underlying Unexercised Options (#) Unexercisable (c) Number of Securities Underlying Unexercised Options (#) Exercisable (b) Option Awards EXECUTIVE COMPENSATION EXECUTIVE COMPENSATION Number of Securities Underlying Unexercised Options (#) Exercisable (column (b)) Number of Securities Underlying Unexercised Options (#) Unexercisable (column (c)) Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (column (d)) Option Exercise Price (column (e)) Option Expiration Date (column (f)) Number of Shares or Units of Stock That Have Not Vested (column (g)) Market Value of Shares or Units of Stock That Have Not Vested (column (h)) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (column (i)) EXECUTIVE COMPENSATION Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (column (j)) 2018 Option Exercises and Stock Vested Name (a) Option Awards Stock Awards Number of Shares Acquired on Exercise (#) (b) Value Realized on Exercise ($) (c) Number of Shares Acquired on Vesting (#) (d) Value Realized on Vesting ($) (e) Option Awards (columns (b) and (c)) Stock Awards (columns (d) and (e)) 2018 Nonqualified Deferred Compensation EXECUTIVE COMPENSATION Name Aggregate Executive Registrant Aggregate Aggregate Aggregate Balance at Contributions Contributions Earnings Withdrawals/ Balance at in Last FY in Last FY in Last FY Distributions Last FYE (1) ($)(2) ($)(3) ($)(4) ($) ($)(1)(5) Potential Payments Upon Termination or Change of Control Summary of Potential Payments EXECUTIVE COMPENSATION Management Continuity Agreements Executive Severance Plan EXECUTIVE COMPENSATION Annual Plan Long-Term Incentive Awards Retirement Benefits Payments and Benefits Upon Termination — As of the End of Fiscal Year 2018 EXECUTIVE COMPENSATION EXECUTIVE COMPENSATION CEO Pay Ratio Disclosure CEO Annual Total Compensation for 2018: $6,127,920 Median Employee Annual Total Compensation for 2018: $48,056 Ratio of CEO to Median Employee Annual Total Compensation for 2018: 128:1 How the Median Employee was Determined in 2017 EXECUTIVE COMPENSATION Compensation Committee Interlocks and Insider Participation Policy on Related Person Transactions Risk Assessment of the Compensation Programs EXECUTIVE COMPENSATION Compensation Committee Report The Compensation Committee of the Board of Directors MISCELLANEOUS MISCELLANEOUS PROVISIONS Voting at the Meeting not Shareholder Proposals MISCELLANEOUS Proxy Solicitation We will furnish without charge to each person from whom a proxy is being solicited, upon written request of any such person, a copy of the Annual Report on Form 10-K of the Company for the fiscal year ending December 31, 2018, as filed with the SEC, including the financial statements and schedules thereto.

SEC Filings

SEC Filings

Registered Drug Master File (DMF)

Patent and Trademark Office for the patent filed for the USee™.

Patent and Trademark Office for the patent filed for the USee™.